• Home
  • About +
    • Our Story
    • Meet the Team
    • FAQs
  • Our Science +
    • Inhaled IFN-β
    • Clinical Trials
    • Publications
    • Factsheets
  • Investors +
    • Investor Overview
    • Investor News
    • Reports & Presentations
    • Major Shareholders & Advisers
    • Shareholder Information
    • Corporate Governance
    • TR-1/Options Press Release Archive
  • Careers
  • Contact
  • Home
  • About
  • Our Science
  • Investors
  • Careers
  • Contact
  • Our Story
  • Meet the Team
  • FAQs
  • Inhaled IFN-β
  • Clinical Trials
  • Publications
  • Factsheets
  • Investor Overview
  • Investor News
  • Reports & Presentations
  • Major Shareholders & Advisers
  • Shareholder Information
  • Corporate Governance
  • TR-1/Options Press Release Archive
← Back to all positions

  • Our Science
  • Interferon Beta
  • Investigating antiviral treatment in COVID-19
  • Prior studies investigating antiviral treatment in COPD
  • Prior studies investigating antiviral treatment in asthma
  • Relevant Publications
  • Factsheets
  • About
  • Home
  • Our Story
  • Team
  • FAQs
  • Careers
  • Contact
  • Investors
  • Investors Overview
  • Investor News
  • Reports & Presentations
  • Asset Match
  • Subscribe to news
Cookie PolicyLegalPrivacy Policy change
© Synairgen. All Rights ReservedRegistered in England and Wales No. 5233429 | Site by Ether